Iris Pecker

This inventor holds 26 USPTO granted patents and 2 published patent applications and 2 EPO patents, primarily in Heparanase Research. Top assignees: Insight Biopharmaceuticals Ltd., Hadasit Medical Research Services and Development Ltd., Insight Strategy Marketing Ltd.. Active years: 1999-2025.

USPTO Granted Patents = 26 (Patent Applications = 2)

% Patents Active = 50.0

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 158(Granted Patents)

Location History:

Rishon le Zion 75203, IL (1999)
Zion, IL (2001)
Rishon Le Zion, IL (2001 - 2011)

Company Filing History:

10 out of 11

Insight Biopharmaceuticals Ltd.

patents

8 out of 181

Hadasit Medical Research Services and Development Ltd.

patents

4 out of 7

Insight Strategy Marketing Ltd.

Insight Biopharmacenticals Ltd.

patent

6. 9 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

Areas of Expertise:

Heparanase

Molecular Probes

Antibodies

Recombinant Proteins

Polynucleotides

Genetically Modified Cells

Anti-Metastatic Agents

Fusion Proteins

Erythropoietin

Polypeptides

Neutralizing Monoclonal Antibodies

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12286466 - PD1-4-1BBL variant fusion protein and methods of use thereof (2025-04-29),

2. 12134638 - SIRPalpha-4-1BBL variant fusion protein and methods of use thereof (2024-11-05),

3. 8048993 - Heparanase specific molecular probes and their use in research and medical applications (2011-11-01),

4. 7893240 - High level expression of recombinant human erythropoietin having a modified 5'-UTR (2011-02-22),

5. 7790376 - Heparanase specific molecular probes and their use in research and medical applications (2010-09-07),

6. 7666651 - Polypeptide having heparanase activity (2010-02-23),

7. 7423139 - High level expression of recombinant human erythropoietin having a modified 5'-UTR (2008-09-09),

8. 7339038 - Heparanase specific molecular probes and their use in research and medical applications (2008-03-04),

9. 7101706 - Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase (2006-09-05),

10. 7049407 - Heparanase specific antibodies and their use in research and medical applications (2006-05-23),

11. 6986996 - Heparanase specific molecular probes and their use in research and medical applications (2006-01-17),

12. 6960471 - Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells (2005-11-01),

13. 6946131 - Heparanase activity neutralizing anti-heparanase monoclonal antibody (2005-09-20),

14. 6800441 - Heparanase specific molecular probes and their use in research and medical applications (2004-10-05),

15. 6790658 - Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells (2004-09-14),

Title: Innovations and Contributions of Iris Pecker

Introduction

Iris Pecker, based in Rishon Lezion, Israel, is an accomplished inventor with an impressive portfolio of 25 patents. His work primarily revolves around novel biopharmaceuticals and molecular probes that have significant implications for research and medical applications.

Latest Patents

One of his most notable recent inventions is the SIRPalpha-4-1BBL variant fusion protein. This innovation includes isolated polypeptides that comprise the SIRPalpha variant, as well as polynucleotides and nucleic acid constructs encoding the fusion protein. Furthermore, he outlines methods of use for these new proteins. Another important patent involves heparanase-specific molecular probes, where he provides an antibody that specifically binds to an epitope of the heparanase protein. This invention holds promise for both research and medical applications, targeting an amino acid sequence with specific modifications.

Career Highlights

Throughout his career, Iris Pecker has made significant contributions, notably during his tenure at Insight Biopharmaceuticals Ltd. His innovative approaches to biotechnology have placed him at the forefront of scientific advancements in the industry.

Collaborations

Pecker has collaborated with esteemed professionals in his field, including Israel Vlodavsky and Maty Ayal-Hershkovitz. These partnerships have likely enriched his research and innovation efforts, fostering a collaborative environment that drives scientific progress.

Conclusion

Iris Pecker's contributions to the world of biotechnology through his numerous patents underscore the importance of innovation in medicine and research. His ongoing work continues to pave the way for advancements that could potentially revolutionize therapeutic approaches and enhance our understanding of complex biological processes.